4.6 Article

Schwann Cell Migration is Integrin-Dependent and Inhibited by Astrocyte-Produced Aggrecan

Journal

GLIA
Volume 58, Issue 7, Pages 857-869

Publisher

WILEY
DOI: 10.1002/glia.20970

Keywords

integrins; chondroitin sulphate proteoglycans; migration; focal adhesion kinase; aggrecan

Categories

Funding

  1. Sims fellowship
  2. James Baird
  3. Medical Research Council
  4. The Wellcome Trust
  5. The Henry Smith Charity
  6. The John and Lucille van Geest Foundation
  7. The European Union Framework 6 Network of Excellence NeuroNE
  8. The European Union Framework 7 Programmes Spinal Cord Repair
  9. Plasticise and Angioscaff
  10. The Christopher and Dana Reeve Foundation
  11. MRC [G0701518] Funding Source: UKRI
  12. Medical Research Council [G0701518] Funding Source: researchfish

Ask authors/readers for more resources

Schwann cells transplantation has considerable promise in spinal cord trauma to bridge the site of injury and for remyelination in demyelinating conditions. They support axonal regeneration and sprouting by secreting growth factors and providing a permissive surface and matrix molecules while shielding axons from the inhibitory environment of the central nervous system. However, following transplantation Schwann cells show limited migratory ability and they are unable to intermingle with the host astrocytes. This in turn leads to formation of a sharp boundary and an abrupt transition between the Schwann cell graft and the host tissue astrocytes, therefore preventing regenerating axons from exiting the graft. The objective of this study was to identify inhibitory elements on astrocytes involved in restricting Schwann cell migration. Using in vitro assays of cell migration, we show that aggrecan produced by astrocytes is involved in the inhibition of Schwann cell motility on astrocytic monolayers. Knockdown of this proteoglycan in astrocytes using RNAi or digestion of glycosaminglycan chains on aggrecan improves Schwann cell migration. We further show aggrecan mediates its effect by disruption of integrin function in Schwann cells, and that the inhibitory effects of aggrecan can overcome by activation of Schwann cell integrins. (C) 2010 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available